Nicholas Latimer

Research Fellow
Address:
HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield S1 4DA
Tel: (+44) (0)114 222 0821
Fax: (+44) (0)114 272 4095
E-mail: n.latimer@sheffield.ac.uk
Room 2029
Biography
I joined ScHARR in June 2008. Before this I graduated with a degree in economics from the University of Nottingham in 2003 and an MSc in Health Economics from the University of York in 2004. I have experience in both the public and the private sectors. I have previously worked as a Research Officer and Analyst at NERA Economic Consulting, a Health Economics Fellow at Queen Mary, University of London (QMUL), and a Health Economist at Roche Products Ltd. While at QMUL I was the principal health economist on the NICE clinical guideline for osteoarthritis. Since joining ScHARR I have worked on clinical trials, the NICE Public Health guidance on the prevention and early identification of alcohol use disorders, and consultancy projects. I organise the Advanced Economic Evaluation module for Masters in Public Health students. In 2009 I was awarded an NIHR Doctoral Research Fellowship.
Research interests
- Economic evaluation
- Health economic modelling
- Survival analysis
- Measuring and valuing uncertainty
Teaching Interests
- Advanced Economic Evaluation, Masters in Public Health
Professional Activities
- I am currently undertaking an NIHR Doctoral Research Fellowship. I am developing a methodological and applied study of the role and value of alternative methods for incorporating survival analysis into economic evaluations of metastatic oncology treatments to inform clinical policy and resource allocation decisions.
Current Projects
- NIHR Personal Award Scheme Fellowship (Award Holder). £265,000 (2009-2012)
Key Publications
- Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J and Conaghan PG. Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDS and Proton Pump Inhibitors. Pharmacoeconomics[accepted for publication]
- Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J and Conaghan PG. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ 2009;339:b2538
- Latimer N. NICE guideline on osteoarthritis: is it fair to acupuncture? Yes. Acupuncture in Medicine 2009;27(2):72-75
- National Collaborating Centre for Chronic Conditions (2008) Osteoarthritis: national clinical guideline for care and management in adults. London: Royal College of Physicians 2008 (Download Appendices D and C for full economic analysis: http://www.rcplondon.ac.uk/pubs/brochure.aspx?e=242)
- Barham L, Lewis D, Latimer N (2007) One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations. Sexually Transmitted Infections 2007;83:441-447
- Barham L, Latimer N, Bramley-Harker E (2005) Coronary heart disease and diabetes – a focus on Scotland. Pharmaceutical Pricing and Reimbursement 2005;10(10):304-305
